Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AA5K
|
|||
| Drug Name |
ACT-101
|
|||
| Indication | Multiple sclerosis [ICD-11: 8A40; ICD-9: 340] | Phase 1 | [1] | |
| Myasthenia gravis [ICD-11: 8C6Y; ICD-10: G70.0; ICD-9: 358] | Phase 1 | [1] | ||
| Company |
Alpha Cancer Technologies Toronto, Canada
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.